Clinical Study

Assessment of Definitions of Sustained Disease Progression in Relapsing-Remitting Multiple Sclerosis

Table 2

Patients who met each definition of sustained progression during followup.

Patients with
sustained progression
Patient with sustained progression
and subsequent visits
Patients who always progressed
among those with subsequent visits
NumberPercent of all patientsNumberPercent of those with sustained progressionNumberPercent of those with subsequent visits

EDSS
 (D1) Increase of 0.539242.231580.413743.5
 (D2) Increase of 127829.922580.99843.6
 (D3) Increase of 1.514715.812081.66150.8
 (D4) Increase of 1/increase 1.5 for baseline EDSS = 021222.816979.77343.2
Functional system
 (D5) Pyramidal function21723.417982.55329.6
 (D6) Cerebellar function12012.99478.32930.9
 (D7) Brainstem function899.66269.71321
 (D8) Sensory function27129.222683.47533.2
 (D9) Bowel bladder function17919.313575.43828.1
 (D10) Mental function16117.311269.64035.7
 (D11) Visual function919.87380.21621.9
Combination of functional system
 (D12) Any FS53657.743380.822852.7
 (D13) First FS53657.743380.812228.2
 (D14) Sum of subscales increase of 224326.2187778545.5
 (D15) Sum of subscales increase of 314815.9111754944.1

A total of 929 patients contributed to the analysis. EDSS: expanded disability status scale.